Schedule 13G ownership disclosure

CRESCENT BIOPHARMA INC.

Ordinary Shares, par value $0.001 per share · CUSIP: G2545C104

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Vestal Point Capital, LP

    Shares: 1,500,000.00 · Class: 5.4%

  • Ryan Wilder

    Shares: 1,500,000.00 · Class: 5.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-26-001077
Form type
SCHEDULE 13G
Filer
CRESCENT BIOPHARMA, INC.
CIK
CIK 1253689
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub